v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities    
Net loss $ (1,792,284) $ (918,382)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation expense 160,036 152,355
Amortization of finance lease right-of-use asset 47,965 47,075
Loss on disposal of property and equipment 558
Change in allowance for doubtful accounts (25,586)
Amortization of debt discounts 14,206 16,419
Stock-based compensation expense 242,812 4,024
Decrease (increase) in assets:    
Accounts receivable 244,738 (1,035,104)
Advances on inventory purchases (23,530) (14,704)
Inventory (1,640,950) 340,668
Prepaid expenses and other current assets (304,694) (108,922)
Other long-term asset and receivable (355,519) (202,464)
Increase (decrease) in liabilities:    
Accounts payable 1,147,064 (56,513)
Accrued expenses 189,800 (162,217)
Net cash used in operating activities (2,095,942) (1,937,207)
Cash flows from investing activities    
Purchase of property and equipment (515,390) (377,841)
Net cash used in investing activities (515,390) (377,841)
Cash flows from financing activities    
Repayment of equipment notes payable (84,235)
Proceeds received on notes payable, related party 1,500,000
Increase in finance lease obligations 2,416 2,398
Proceeds from sale of common stock pursuant to ATM program 1,429,044 2,407,448
Proceeds from exercise of warrants 37,500 38,157
Net cash provided by financing activities 2,968,960 2,363,768
Effect of exchange rate changes on cash (56,245) 8,209
Net increase (decrease) in cash 301,383 56,929
Cash - beginning of period 616,278 2,329,452
Cash - ending of period 917,661 2,386,381
Supplemental disclosures:    
Interest paid 23,862 84,571
Income taxes paid
Non-cash investing and financing transactions:    
Conversion of convertible debt into common stock $ 500,000